Eddy P Lincango, Luis A Figueroa, Cristina Arias Cortez, Doménica Herrera Hernandez, Emily Rivadeneira Cabezas, Francisco Rivadeneira Proaño, Pedro Isaac Torres Balarezo, Domenica Brito, Luis Serrano, Adela Casas-Melley, Dustin Huynh, Alvaro Sanabria, Bradley Johnson, Benjamin James, Lilah Morris-Wiseman, Julie A Sosa, Benzon Dy, Minerva A Romero Arenas, Carmen C Solorzano, Sophie Dream, Juan P Brito
{"title":"Safety of surgery for managing hyperthyroidism in patients with or without preoperative euthyroidism: A systematic review and meta-analysis.","authors":"Eddy P Lincango, Luis A Figueroa, Cristina Arias Cortez, Doménica Herrera Hernandez, Emily Rivadeneira Cabezas, Francisco Rivadeneira Proaño, Pedro Isaac Torres Balarezo, Domenica Brito, Luis Serrano, Adela Casas-Melley, Dustin Huynh, Alvaro Sanabria, Bradley Johnson, Benjamin James, Lilah Morris-Wiseman, Julie A Sosa, Benzon Dy, Minerva A Romero Arenas, Carmen C Solorzano, Sophie Dream, Juan P Brito","doi":"10.1007/s12020-025-04340-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Guidelines recommend achieving normal thyroid function (euthyroidism) before thyroid surgery to treat hyperthyroidism due to concerns about uncontrolled thyroid hormone release during surgery. However, achieving euthyroidism before surgery may not always be possible. We aim to evaluate postoperative outcomes of hyperthyroid patients who were euthyroid versus those who were not before thyroid surgery.</p><p><strong>Methods: </strong>We searched Medline, Embase, Scopus, and Cochrane from inception to July 2023 to identify comparative studies on hyperthyroid patients who were euthyroid or hyperthyroid (elevated thyroxine levels) before surgery. We evaluated post-surgical complication rates in each group. A random-effects model was used to consolidate dichotomous variables with odds ratios (OR) and continuous variables with mean differences (MD), both with 95% confidence intervals (95% CI). The risk of bias was assessed using the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>We included eight retrospective cohort studies involving 1336 patients, of whom 33.6% (n = 449) were biochemically hyperthyroid at the time of thyroidectomy. Most of these patients were female (67.2%, n = 899), with an average age (SD) of 38.73 ± 2.80 years, and had Graves' Disease (96%). The mean (SD) preoperative TSH was 0.28 ± 0.10 mIU/L, FT4 was 3.33 ± 0.64 ng/dL, and FT3 was 67.65 ± 22.41 pg/mL. No significant differences were observed in postoperative complications between preoperatively euthyroid and hyperthyroid patients. This includes temporary hypocalcemia (OR: 0.50, 95% CI: 0.20-1.29, I<sup>2</sup>: 42.7%, n = 521), permanent hypocalcemia (OR: 0.46, 95% CI: 0.11-1.96, I<sup>2</sup>: 0.0%, n = 727), temporary hoarseness (OR: 1.46, 95% CI: 0.59-3.64, I<sup>2</sup>: 0.0%, n = 541), permanent hoarseness (OR: 0.74, 95% CI: 0.13-4.34, I<sup>2</sup>: 0.0%, n = 727), bleeding risks (OR: 0.27, 95% CI: 0.06-1.28, I<sup>2</sup>: 0.0%, n = 541), length of hospital stay (MD: 0.0, 95% CI: -0.2-0.2, n = 379), and operative time (MD: -5.6, 95% CI: -15.4-4.3, n = 674). There was one case of thyroid storm after surgery in the hyperthyroid group, with no mortalities reported. The risk of bias was moderate in six studies and high in two.</p><p><strong>Conclusions: </strong>Low-to-moderate quality evidence suggests preoperatively euthyroid patients undergoing total thyroidectomy have lower risks of hypocalcemia, hoarseness, and hematoma than hyperthyroid patients, though differences are not statistically significant. These findings can guide recommendations for hyperthyroidism management and help clinicians weigh surgical risks and benefits for hyperthyroid patients.</p>","PeriodicalId":11572,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04340-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Guidelines recommend achieving normal thyroid function (euthyroidism) before thyroid surgery to treat hyperthyroidism due to concerns about uncontrolled thyroid hormone release during surgery. However, achieving euthyroidism before surgery may not always be possible. We aim to evaluate postoperative outcomes of hyperthyroid patients who were euthyroid versus those who were not before thyroid surgery.
Methods: We searched Medline, Embase, Scopus, and Cochrane from inception to July 2023 to identify comparative studies on hyperthyroid patients who were euthyroid or hyperthyroid (elevated thyroxine levels) before surgery. We evaluated post-surgical complication rates in each group. A random-effects model was used to consolidate dichotomous variables with odds ratios (OR) and continuous variables with mean differences (MD), both with 95% confidence intervals (95% CI). The risk of bias was assessed using the Newcastle-Ottawa Scale.
Results: We included eight retrospective cohort studies involving 1336 patients, of whom 33.6% (n = 449) were biochemically hyperthyroid at the time of thyroidectomy. Most of these patients were female (67.2%, n = 899), with an average age (SD) of 38.73 ± 2.80 years, and had Graves' Disease (96%). The mean (SD) preoperative TSH was 0.28 ± 0.10 mIU/L, FT4 was 3.33 ± 0.64 ng/dL, and FT3 was 67.65 ± 22.41 pg/mL. No significant differences were observed in postoperative complications between preoperatively euthyroid and hyperthyroid patients. This includes temporary hypocalcemia (OR: 0.50, 95% CI: 0.20-1.29, I2: 42.7%, n = 521), permanent hypocalcemia (OR: 0.46, 95% CI: 0.11-1.96, I2: 0.0%, n = 727), temporary hoarseness (OR: 1.46, 95% CI: 0.59-3.64, I2: 0.0%, n = 541), permanent hoarseness (OR: 0.74, 95% CI: 0.13-4.34, I2: 0.0%, n = 727), bleeding risks (OR: 0.27, 95% CI: 0.06-1.28, I2: 0.0%, n = 541), length of hospital stay (MD: 0.0, 95% CI: -0.2-0.2, n = 379), and operative time (MD: -5.6, 95% CI: -15.4-4.3, n = 674). There was one case of thyroid storm after surgery in the hyperthyroid group, with no mortalities reported. The risk of bias was moderate in six studies and high in two.
Conclusions: Low-to-moderate quality evidence suggests preoperatively euthyroid patients undergoing total thyroidectomy have lower risks of hypocalcemia, hoarseness, and hematoma than hyperthyroid patients, though differences are not statistically significant. These findings can guide recommendations for hyperthyroidism management and help clinicians weigh surgical risks and benefits for hyperthyroid patients.
期刊介绍:
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.